Skip to content

Clinical trials

Terminated Anemia, Refractory trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory Status: Terminated Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20051
20062
20073
20091
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
Wake Forest University Health Sciences2
Alison Walker1
CTI BioPharma1
H. Lee Moffitt Cancer Center and Research Institute1
Jonsson Comprehensive Cancer Center1
Masonic Cancer Center, University of Minnesota1
OHSU Knight Cancer Institute1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
University of Medicine and Dentistry of New Jersey1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory13
Anemia, Refractory, with Excess of Blasts13
Myelodysplastic Syndromes13
Leukemia11
Leukemia, Myelomonocytic, Chronic10
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Leukemia, Lymphocytic, Chronic, B-Cell6
Leukemia, Myeloid, Acute6
Multiple Myeloma6
Myelodysplastic-Myeloproliferative Diseases6

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.